MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis
A Double-Blind, Randomized, Parallel-Group Study to Investigate the Pharmacokinetic and Clinical Similarity Between MabionCD20, EU-approved MabThera® and US-licensed Rituxan® in Patients With Moderate-to-Severe Rheumatoid Arthritis A Double-Blind, Randomized, Parallel-Group Study toInvestigate the Pharmacokinetic and Clinical Simi ...